Platelets contribute to prethrombotic or thrombotic states; however, accepted evaluation methods (i.e., in vitro testing by use of an aggregometer) of platelet function in cats can be difficult because of the large volume of blood required from which platelets are isolated and the potential for platelet activation due to difficult venipunctures in sometimes uncooperative or excited animals. The activation problem also contributes to errors in platelet counts. Platelets from four domestic short haired cats (two males, two females, 2-3 years old) minimally restrained without sedation or anesthesia were evaluated. Blood ( 5 ml) was collected by jugular venipuncture directly into syringes containing 3.8% trisodium citrate (nine parts blood to one part anticoagulant) plus prostaglandin E, (3 pM; 0.25, 0.5, 1, or 2 p1/500 p1 citrate) or 3.8% trisodium citrate alone. Prostaglandin E,, which is a stable metabolite of arachidonic acid with platelet inhibitory properties similar to those of prostaglandin I,, was added to the anticoagulant to prevent activation of platelets during the collection process. Feline platelets exposed to prostaglandin El became immediately and persistently nonreactive to agonists, which negated their use in functional studies (aggregation, 14C-~er~tonin release, binding of fluorescein-conjugated antifibrinogen) but improved platelet counting accuracy. Detection of in vivo activation of platelets in prethrombotic and thrombotic states in humans has been done by identification of activation-dependent molecules on platelet surfaces by use of specific antibody recognition and detection by flow cytometric analysis. Many activation-dependent platelet surface receptor changes are species specific; however, fibrinogen appears to be conserved across species. Results of flow cytometric analysis by forward and side angle light scatter easily identified feline platelets in 10 pl of platelet-rich plasma but were less definitive in identification of platelets in whole blood. Feline platelets in platelet-rich plasma activated by ADP (5 or 50 pM), which allowed binding of fibrinogen to exposed fibrinogen receptors, were labeled with fluorescein-conjugated anti-human fibrinogen. Labeled platelets were identified as a separate population by flow cytometric staining pattern and fluorescence intensity from nonlabeled platelets or nonspecifically-labeled resting platelets. This technique should allow detection of activated feline platelets from extremely small quantities of blood, which could facilitate repetitive and serial platelet testing in diseases thought to be accompanied, caused, or augmented by thrombotic conditions.
Vet Pathol 315, 1994 platelets are isolated. Cats, as compared with most domestic animals and people, have less relative and total blood volume (200-250 ml, 0.05 liters/kg),' and collection of an adequate blood sample is often a problem, especially from ill cats. This makes repetitive and sequential studies on platelets in cats extremely difficult. Additionally, cats have small vessels for venipuncture, and because of their temperament cats may be poor candidates for proper collection of platelets. Ideal methods of testing feline platelets should require only small quantities of blood and minimize the risk of activation due to collection procedures.
Thrombotic conditions in various diseases may be contributed to, caused by, or enhanced by in vivo activation of platelets. Detection of platelets activated in vivo has been studied in various human prethrombotic and thrombotic disorders. 13~17, 22 Activated platelets have been identified by detection of specific cell surface receptors that are present only after platelet activation. Flow cytometric analysis of fluorescein-or enzymelabeled antibodies to these exposed receptors has been successful.2~3 Most receptors are glycoproteins that are species specific. However, fibrinogen is fairly well conserved across species and may be useful in evaluation of activated feline platelets. Fibrinogen becomes bound on activated platelets to the fibrinogen receptor, a complex formed by glycoproteins IIb (GPIIb) and IIIa (GPIIIa).
One objective of the present study was to evaluate an alternative method for collecting and processing feline blood for the study of platelet function. Blood (5 ml) was collected with an inhibitor of platelet activation (prostaglandin El [PGE,]) added to 3.8% trisodium citrate anticoagulant. Prostacyclin (PGI,), which is a known inhibitor of platelet activation, will temporarily inhibit in vitro platelet activation. It is unstable and requires strict handling procedures. Prostaglandin El is a stable metabolite of arachidonic acid with platelet inhibitory properties similar to those PGI, as tested in people. Another objective was to develop and evaluate a sensitive and specific in vitro method of detecting activated platelets by use of flow cytometric analysis of activation-dependent binding of fibrinogen to the surface of platelets.
Materials and Methods

Cats
Four domestic short haired cats (two male, two female), 2-3 years of age, were gang housed (by sex) in an indoor room with nutritionally complete commercial dry feed and water available ad libitum. Experimental protocols covering all aspects of this study were approved by the Auburn University Animal Care and Use Committee.
Sample collection
Whole blood was drawn via jugular venipuncture directly into syringes containing either 3.8% trisodium citrate (nine parts blood to one part anticoagulant) or 3.8% trisodium citrate with PGE, (Sigma Chemical Co., St. Louis, MO) ( 1 p1 of 3 pM PGE,/SOO pl 3.8% trisodium citrate, nine parts blood to one part anticoagulant). Lyophilized PGE, was dissolved in 95% ethanol and stored at -70 C until use. Food was withheld overnight from cats prior to each sample collection to assure nonlipemic samples, because lipemia interferes with aggregation studies. Cats were restrained gently without sedation or anesthesia.
Platelet-rich plasma preparation
Whole blood was maintained at room temperature and gently rocked for 30 minutes prior to harvesting platelet-rich plasma (PRP). Platelet populations were harvested from blood after each of three consecutive centrifugations (CRU-5000 centrifuge, Damon/International Equipment Co., Needham Heights, MA) at decreasing RPM. Platelet count and mean platelet volume were determined using an automated platelet counter (Baker series 8 10, Baker Instruments Corp., Allentown, PA). Samples were adjusted to 300,000 plateletdpl using autologous platelet-poor plasma.
Platelet aggregation studies
Platelet aggregation was performed with a dual channel aggregometer (Chrono-log model 450, Chrono-log Corp., Havertown, PA) equipped with a r e c~r d e r .~.~ Aggregation responses were evaluated using varied concentrations of adenosine diphosphate (ADP grade I; Sigma Chemical Co.) and collagen as agonists. Adenosine diphosphate was prepared by dissolution in deionized water (stock solution 1,000 pM), aliquoted, and stored at -20 C until use. A stock solution of collagen (230 pglml, type I, bovine achilles tendon; Sigma Chemical Co.) was ~r e p a r e d ,~.~ aliquoted, and stored at -80 C until use. The aggregation reactions were stopped after 3 minutes.
Platelets were washed at different steps in the experiments. Samples were centrifuged (Eppendorf Centrifuge 54 15, Brinkmann Instruments Co., Westbury, NY) at 15,000 RPM for 10 seconds, the supernatant was discarded, and Tangen-HEPES buffer (HEPES 10 mM, NaCl 145 mM, KCI 5 mM, MgSO, 1 mM, pH 7.4) or Tangen-HEPES buffer with 2% formalin was added to attain original volume.
Platelet flow cytometric studies
Platelet-rich plasma (10 pl, ~3 0 0 , 0 0 0 platelets/pl) was diluted in Tangen-HEPES buffer (1 00 pl). Platelets were activated with ADP (10 pl; 5 , 10, or 50 pM, 5 minutes, 20-22 C) and tagged with fluorescein-labeled anti-human fibrinogen (fluorescein-conjugated goat F[ab'], fragment to human fibrinogen, Cappel-Organon Teknika Corp., Durham, NC) (20 pl; 1 : 50 dilution, 30 minutes, 20-22 C). After activation and antibody labeling, the platelets were fixed (200 ml, 2% formalin in Tangen-HEPES buffer) and washed once and resuspended in Tangen-HEPES buffer with 2% formalin. Controls were run concomitantly, including 1) PRP + ADP and 2) PRP + fluorescein isothiocyanate (FITCFantifibrinogen.
Samples were analyzed using a flow cytometric instrument (Coulter Elite, Coulter Cytometry, Hialeah, FL), and data were displayed graphically and collected in list mode on disks for further analysis. A gate was set around the platelets, and 10,000 events were analyzed for FITC fluorescence to quantitate the amount of fluorescein-labeled antifibrinogen bound to platelets.
Statistical analysis
Group means of the two dependent variables, percentage of light transmission and percentage of I4C-serotonin release, were compared with an analysis of variance for samples drawn in 3.8% trisodium citrate with PGE, and in 3.8% trisodium citrate alone for each concentration ofagonist. Agonist (either ADP or collagen) and agonist concentration were not considered independent variables in this analysis. Group means were considered significantly different when P < 0.05. Calculations were performed with the aid of a statistical software package (BMDP 7D Statistical Software, Los Angeles, CA). Antibody binding was expressed as mean fluorescence intensity. 30 Fluorescence signal-to-noise ratio3) (FSN ratio) was determined as 1 O(Ch#cxp-Ch#ctl)'#chD); where Ch#exp = measured linear mean channel number of experimental sample; Ch#ctl = measured linear mean channel number of negative control; and #ChD = number of channels per
The FSN (fluorescence intensity above background) was used to express the difference in antibody binding induced by different degrees of activation of platelets by ADP.
Results
Reactivity of platelets with and without PGE,
Platelets collected into 3.8% trisodium citrate only had percentage light transmission (%LT) and percentage I4C-serotonin release (YoSR) ( Table 1) that were consistent among the cats, with increasing platelet aggregation and granule release after exposure to increasing concentrations of ADP or collagen. Platelets harvested from blood drawn in 3.8% citrate with PGE, (Table 1) had markedly decreased to no change in VOLT or %SR in response to any concentration of either agonist compared with platelets without exposure to PGE, ( Fig. 1 ).
Effect of PGE, on platelet reactivity
To determine the optimal concentration of PGE,, blood was drawn in syringes containing 3.8% trisodium citrate (nine parts blood to one part anticoagulant) with various amounts of PGE,:2, 1,0.5, or 0.25 pl of 3 pM PGE,/SOO pl of 3.8% trisodium citrate. Platelets (Fig.  2) were minimally reactive to collagen (3 pg/dl) with 0.25 pl and 0.5 pl of PGE,/5OO p1 of 3.8% trisodium citrate and to ADP (2.5 pM) with 0.25 pl of PGE,/5OO pl of 3.8% trisodium citrate. At other concentrations of PGE,, using either ADP or collagen as agonist, platelets practically were nonreactive (Fig. 2 ).
Allowing extended time ( 3 hours) between collection of platelets in PGE, and determination of reactivity of platelets did not alter platelet responses to agonists (data not shown).
Platelets washed once or twice to remove PGE, were not different in reactivity from unwashed platelets. However, after three washings, platelets spontaneously aggregated prior to addition of agonist.
Effect of ethanol on platelet reactivity
Ethanol was the solvent for PGE,; therefore, its effect on platelet reactivity had to be determined. Blood was drawn into syringes containing 3.8% trisodium citrate (nine parts blood to one part anticoagulant) with various amounts of ethanol that were similar to concentrations that would have been added with PGE,:l pl of 95%, 76%, 50% or 0% ethano1/500 pl citrate. Ethanol at these concentrations had no effect on platelet aggregation and release in response to 2.5 gM ADP or 3.0 pg/ml collagen (data not shown). 
Flow cytometric analysis of platelets
Platelets (Fig. 3, left) in PRP were identified by forward (size) and side (granularity) angle light scatter. Unfixed platelets were slightly larger than fixed platelets ( Fig. 3 , middle) . Unactivated fixed platelets were identified as an indistinct population in whole blood (Fig. 3, right) , but activated fixed platelets were more difficult to discern from erythrocytes and leukocytes in whole blood (data not shown); therefore, PRP was used in all subsequent tests.
Populations of platelets were identified by fluorescence intensity depending on state of activation and degree of FITC-antifibrinogen binding. Platelets activated by ADP and labeled with antibody (c) were compared with platelets activated by ADP with no antibody labeling (a) and with platelets nonspecifically labeled with antibody (b and b,) ( Fig. 4) . Trials were performed to determine optimal concentrations of ADP and fluorescence-labeled antifibrinogen. Three concentrations of ADP (5, 10, or 50 pM) were studied. Activation by 50 pM ADP generated 0-2.7 times as much antibody binding as did 5 pM ADP (data not shown).
Two different fluorescein-labeled antifibrinogen products, fluorescein-conjugated goat F(ab')2 fragment to human fibrinogen (Cappel-Organon Teknika Corp.) and FITC-conjugated rabbit anti-human fibrinogen (DAKO Corp., Carpinteria, CA), were tried. The rabbit compound had increased nonspecific binding and, when added at high concentrations, was capable of activating platelets without agonist. This antibody was not selected for further study.
Platelets harvested from blood drawn in citrate with PGE, had pattern and fluorescence staining intensity similar to those of unactivated platelets (Fig. 5 ). Plate- lets activated with either 5 or 50 pM ADP (1 5 minutes) and then exposed to PGE, (final concentration of PGE, comparable to concentration present in anticoagulant solution used for drawing blood) had pattern and fluorescence staining intensity similar to those of unactivated platelets or platelets harvested from blood drawn in citrate and PGE, (data not shown).
Discussion
We evaluated collection of small blood samples via jugular venipuncture directly into 3.8% trisodium citrate with PGE, as an alternative method of collecting and processing blood for the study of feline platelet function. Close simulation of a clinical setting of patient handling and blood collection was attempted; therefore, cats were handled with minimal restraint with no sedation or anesthesia, and small quantities of whole blood were collected (5 ml). Prostaglandin E, is a stable metabolite of arachidonic acid with properties very similar to those of PGI,.1725 Although prostaglandin E, is a physiologic metabolite of membrane arachidonic acid (similar to PGI,) that has platelet Representative scatterplots of feline platelets identified by forward (size) and side (granularity) angle light scatter: fixed platelets (PRP) (left), unfixed platelets (PRP) (middle), and platelets, erythrocytes and leukocytes (whole blood) (right). Fixed platelets are slightly larger (shifted to the right on the x-axis) than nonfixed platelets. In whole blood, platelets are less definitively identified as a group.
aggregation inhibitory it has poor stability (personal ob~ervation).~~ A concentration of 3 pM PGE, was selected based on studies with canine platelets, and various amounts of PGE, were evaluated. Prostaglandin El at all concentrations evaluated was a potent inhibitor of feline platelet aggregation and 14Cserotonin release. Its effects did not diminish appreciably over time. Platelets become progressively less reactive with storage at room temperature (20-22 C) as the period of time increases after colle~tion;~ therefore, it was unrealistic to extend the wait period more than 3-4 hours. Feline platelets exposed to PGE,, either prior to or after ADP activation, became inactive, as analyzed by flow cytometric studies. The antiaggregatory functions of PGE, are the result of its ability to increase cytoplasmic CAMP, which leads to reduced mobilization of calcium ions from internal stores (dense granules) or from the external e n~i r o n m e n t . *~,~~ Feline platelets responded similarly to human platelets when exposed to PGE, prior to agonist addition; activation and binding of fibrinogen were Similar results have been seen when PGI, was added to human platelets prior to activation.' Also, deactivation or relaxation of human ADP-aggregated platelets has been observed following addition of PGE, ,,' which is probably the reason that activated feline platelets became inactivated after exposure to PGE, . Contrasting results were obtained from one study, in which activated fluorescein-labeled platelets could be detected when added to a platelet population exposed to PGI, in order to render them inactive.29 Feline platelets were washed in an attempt to remove PGE, and its effects, but they showed no improvement in aggregation responses after one or two washings, and after three washings, they aggregated spontaneously prior to addition of agonist.
Spontaneous aggregation of feline platelets never occurred in blood samples collected in citrate with PGE, , whereas aggregation occurred in several blood samples drawn into citrate alone for various reasons, such as prolonged time for sample collection or difficult venipuncture. Therefore, platelet counts from samples collected in citrate with PGE, always could be performed with assurance that platelet aggregates and clumps would not be a cause of inaccuracy. This method of feline blood collection may improve the accuracy of platelet counting. It was hoped that in vivo platelet activation could be detected in prethrombotic or thrombotic disease conditions if a method of blood sample collection could be developed in which the activated state of platelets could be preserved and no additional activation of platelets would be induced by the collection proce-Vet Pathol 315, 1994 log fluorescence Intensity Fig. 4 . Different populations of feline platelets were determined by fluorescence intensity depending on state of activation and degree of FITC-antifibrinogen binding: platelets activated with ADP with no label (a), platelets nonspecifically reacting with FITC-antifibrinogen (b, unactivated; b,, activated with ADP), and platelets activated with ADP and labeled with FITC-antifibrinogen (c). Activated labeled platelets (c) had 18 times more fluorescence than platelets with nonspecifically bound label (b, b , ) and 180 times more fluorescence than nonlabeled resting platelets (a).
dures. However, because of the potent antiaggregatory effects of PGE, , it was unsuitable for use in activation studies. Based on observed reversal of in vitro ADPinduced platelet activation by PGE, exposure, it will not be feasible to use PGE, plus anticoagulant for collection of patient samples to be used in assessment of in vivo platelet activation. Additionally, washing of platelets to remove PGE, does not appear to be a realistic alternative.
We evaluated feline platelet detection by flow cytometric analysis of size and granularity. Feline platelets were readily identified in samples of PRP but were less definitively identified in samples of whole blood. The variability in feline platelet size compared with erythrocyte size most likely contributed to this difficulty.
Detection of activated feline platelets by use of flow cytometric identification of fluorescent antibody-labeled specific activation-dependent molecules on the platelet surface in combination with knowledge of platelet size and granularity was evaluated. Activated human platelets have been identified using flow cytometric analysis of numerous monoclonal antibodies to specific membrane-associated complexes; 1,10,24 however, none are specific for activated feline platelets. This detection is dependent on platelet surface receptor changes that occur after exposure to various soluble agonists, such as ADP, collagen, prostaglandin endoperoxides, and thrombin. Although these compounds most likely have specific membrane receptors, their binding initiates a set of common internal responses from p l a t e l e t~.~~.~~.~~.~9 .~~.~~ Additionally, specific antibodies have been produced that detect substances re-log fluorescence Intensity Fig. 5 . Representative fluorescence intensity of feline platelets exposed to PGE, (0 compared with activated nonlabeled platelets (a) and resting platelets nonspecifically reacting with FITC-antifibrinogen (b). Unlabeled activated platelets (a) had minimal autofluorescence. Platelets exposed to PGE, (f) were prevented from becoming activated and lack significant antifibrinogen binding, similar to resting platelets (b).
leased from platelet granules such as fibrinogen, thrombospondin, and von Willebrand factor.2J6.2L Alteration of membrane GPIIb-IIIa complex into a functional receptor for fibrinogen is an activation-dependent platelet surface ~h a n g e .~~.~~ Aggregation of platelets is dependent on 1,23,24 or enhanced by8,9,22 fibrinogen binding to platelets. The antigenic structure of fibrinogen is fairly well conserved across species, as evidenced by cross-reactivity between anti-human fibrinogen molecules and bovine, equine, and murine fibrinogen (personal communication, Cappel-Organon Teknika). Data from studies documenting cross-reactivity of anti-human fibrinogen with feline fibrinogen were not available; however, our data demonstrate the recognition of a platelet bound product, presumably fibrinogen. Feline platelets labeled with fluorescent antibody were identified by dark-field microscopy (photographs not shown).
Nonactivated feline platelets and platelets rendered nonactive by exposure to PGE, bound some FITCantifibrinogen. This nonspecific antibody binding may be attributed to the presence of some fibrinogen on the surfaces of platelets19 or to the binding of the antibody to other surface receptors, such as Fc receptors, which platelets p o s~e s s .~J~.~~ Greater nonspecific binding was observed with one product that was intact immunoglobulin (DAKO Corp.) as compared with a product that was the F(ab'), fragment of IgG (Cappel-Organon Teknika). Thereafter, the F(ab'), product was used. Also, high concentration of the intact immunoglobulin was capable of inducing platelet activation (data not shown). One theory holds that antibodies bound to platelets also bound each other; thereby putting platelets in close proximity with induction of thromboxane synthesis, leading to secretion and aggregati~n.~ An-other phenomenon is that the antibody can form a linkage between antigen (fibrinogen) and receptor (Fc receptor) on adjacent platelets, thereby putting platelets in close proximity and signaling aggregation and granule ~e c r e t i o n .~~ Flow cytometric analysis of feline platelets activated by ADP showed markedly increased FITC-antifibrinogen labeling as compared with nonactivated platelets. Resting platelets have approximately 70% of the GPIIb-IIIa complexes distributed randomly on their surface, with the remaining complexes located within membranes of the canalicular system and a -g~a n u l e s .~~ Activation induces release of granule contents with increased numbers of GPIIb-IIIa complexes present o n the platelet surface." By use of flow cytometric analysis, a specific monoclonal antibody against GPIIb-IIIa has been successful in the detection of activated human platelets.' Observed patterns of nonspecific antibody binding to resting human platelets (platelets exposed to PG12) and enhanced binding subsequent to platelet activation were similar to our observations.
Microparticles were observed in samples of activated feline platelets as small particles of low granularity that were detected in the noise region of the flow cytometric scattergrams. Platelet-derived microparticles'J1 generated during activation are thought to be glycoprotein-rich membrane fragments that may have prothrombotic functional significance. Also, larger aggregates of platelets or platelets plus microparticles were detected as larger, increased granularity particles on the flow cytometric scattergrams. Both of these entities were difficult to analyze because they fell outside the determined platelet gate.
In conclusion, blood samples collected from cats that were minimally restrained without sedation or anesthesia were adequate for platelet isolation and flow cytometric analysis. Fluorescein-labeled anti-human fibrinogen is capable of cross-reacting with fibrinogen attached to feline platelets. Staining intensity and pattern as determined by flow cytometric analysis can distinguish activated from nonactivated platelets.
Platelets exposed to PGE, , either prior to or after stimulation by agonists, become nonactive and have minimal antifibrinogen binding. Citrate with PGE, as anticoagulant for blood samples gives excellent results for platelet counting. However, it is an unacceptable anticoagulant for determination of in vivo activation of platelets by flow cytometric methods.
